Table 1 Demographic and clinical characteristics of newborns of SARS-CoV-2 positive mothers.

From: Newborns of COVID-19 mothers: short-term outcomes of colocating and breastfeeding from the pandemic’s epicenter

Characteristics

Patients/Value (N = 45)

Maternal characteristics

 Age, median (IQR), years

30 (27.5–35.5)

 Vaginal delivery, no. (%)

30 (66.7)

 Cesarean section, no. (%)

15 (33.3)

 Length of stay, median (IQR), days

3 (2–3)

 Asymptomatic, no. (%)

27 (60)

 Symptomatic, no. (%)

18 (40)

 Symptoms, no. (%)

  Fever

15 (33.3)

  Cough

16 (35.6)

  Sore throat

4 (8.9)

  Shortness of breath

6 (13.3)

 Intensive care unit admission, no. (%)

2 (4.4)

 Mothers needing intubation, no.

0

 Treatment with medications for COVID-19, no. (%)

 

  Hydroxychloroquine

6 (13.3)

  Azithromycin

5 (11.1)

  Tocilizumab

1 (2.2)

Newborn characteristics

 Birth weight, mean (±SD), g

3133 (±556)

 Sex, no. (%)

  Female

19 (42.2)

  Male

26 (47.8)

 Gestational age, mean (range), weeks

34 (30 5/7–41)

 Term (>37 weeks), no. (%)

41 (91.1)

 Preterm (<37 weeks), no (%)

4 (8.9)

 APGAR at 1 min, median

9

 APGAR at 5 min, median

9

 NICU admission, no. (%)

7 (15.6)

  Prematurity

3/7 (42.8)

  Suspected sepsis

4/7 (57.2)

 Isolation during initial practice, no. (%)

5 (11.1)

 Breastfeeding and colocation, no. (%)

  Roomed-in

33 (73.3)

  Breastfeeding

31/33 (94)

  Received any breastmilk

40 (88.9)

 Nasopharyngeal PCR positive for SARS-CoV-2, no. (%)

3 (6.7)

 Newborn with symptoms of COVID-19, no.

0

 Discharge disposition, no. (%)

  Discharge to the same household

40/43 (93.0)

  Discharge to different household

3 (7.0)

 Adherence to in-person newborn visit, no. (%)

39/43 (90.6)

 Symptomatic on in-person newborn visit, no.

0

Adherence to televisit, no. (%)

43/43 (100)

Symptomatic on televisit, no.

0